Clinical Trial Update: A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial to evaluate the safety of Belumosudil in participants aged 12 years and older with chronic graft-versus-host disease; the study is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Belumosudil (belumosudil)

Snippet

Sponsor: Sanofi | Conditions: Chronic Graft Versus Host Disease | Phase 4 | Status: NOT_YET_RECRUITING